Posted by Michael Wonder on 16 Jan 2025
Incyte and Syndax announce US FDA approval of Niktimvo (axatilimab-csfr) 9 mg & 22 mg vial sizes
15 January 2025 - US launch expected in early February.
Incyte and Syndax Pharmaceuticals today announced that the US FDA has approved Niktimvo (axatilimab-csfr) in 9 mg & 22 mg vial sizes.
